Xizang Weixinkang Pharmaceutical Co., Ltd. Class ASSE: 603676

Announcement on Subsidiary Obtaining Notice of Approval for Drug Clinical Trials

· Issued by Xizang Weixinkang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Subsidiary Obtaining Notice of Approval for Drug Clinical Trials

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment